References
- Cazenave J P, Benveniste J, Mustard J F. Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs. Lab Invest 1979; 41: 275–285
- Rao H R, Reddy K R, White J G. The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated platelets. Prostaglandins Med 1980; 4: 385–397
- Kinlough-Rathbone R L, Mustard J F, Perry D W. Factors influencing the deaggregation of human and rabbit platelets. Thromb Haemost 1983; 49: 162–167
- Feinstein M B, Egan J J, Shaafi R I. Cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, Forskolin). Biochem Biophys Res Commun 1983; 113: 598–604
- Khan S N, Smith A D. Effect of verapamil and lanthanum on PAF-induced aggregation of rabbit platelets in vitro. Br J Pharmacol 1983; 78: 181P
- Coeffier E J, Cerrina E, Jouvain-Marche E. Inhibition of rabbit platelet aggregation by the Ca2+ antagonists verapamil, and diltiazem and by trifluoroperazine. Thromb Research 1983; 31: 565
- Han P C, Boatwright C, Ardle N G. Verapamil and collagen induced platelet reactions—evidence for a role for intracellular calcium in platelet activation. Thromb Haemost 1983; 50: 537–540
- Khan S N, Lane P A, Smith A D. Desaggregation of PAF-acether aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins. Eur J Pharmacol 1985; 107: 189–198
- Homa S T, Khan S N, Conroy D M. Verapamil inhibits phosphatidic acid formation and modifies phosphoinositide metabolism in stimulated platelets. Eur J Pharmacol 1990; 182: 457–464
- Khan S N, Oppong S, Conroy D M. Synergistic effect of PGE1 and the calcium antagonist verapamil in disaggregation of aggregated platelets and inhibition of aggregation induced by PAF-acether or arachidonic acid. Prog Lipid Res 1986; 25: 295–299
- Haslam R J, Salama S E, Fox J E B. Roles of cyclic nucleotides and of protein phosphorylation in the regulation of platelet function. Platelets: Cellular response mechanisms and their biological significance, A Rotman, F A Meyer, G Gitler, A Suberg. John Wiley and Sons, New York 1980; 213–231
- Nishizuka Y. Phospholipid degradation and signal transduction for protein phosphorylation. Trends Biochem Sci 1983; 8: 13–16
- Nishizuka Y, Takai Y, Kishimoto A. Phospholipid turnover in hormone action. Recent Prog Horm Res 1984; 40: 301–343
- White J G. Fine structural alterations induced in platelets by adenosine diphosphate. Blood 1968; 31: 604–622
- White J G. The morphology of platelet function. Measurements of platelet function, L A Harker, T S Zimmerman. Churchill Livingstone, Edinburgh 1983; 1–25
- White J G. Platelet morphology. The circulating platelet, S A Johnson. Academic Press, New York 1971; 45–121
- White J G, Clawson C C. The biostructure of platelets. Ultrastructural Pathol 1980; 1: 533–558
- Zila P, Groscurth P, Rhyner K. Surface morphology of human platelets during in vitro aggregation. Scand J Haematol 1984; 33: 440–447
- Ikeda Y, Kikuchi M, Toyama K. Inhibition of human platelet functions by verapamil. Thromb Haemost 1981; 45: 158–61